Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 19, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- September 14, 2006: Transfer of 9,075 Ordinary Shares (advised on September 19, 2006).
- September 15, 2006: Transfer of 10,390 Ordinary Shares (advised on September 18, 2006).
- September 18, 2006: Transfer of 2,952 Ordinary Shares (advised on September 19, 2006).
Total shares transferred in this notification: 22,417 Ordinary Shares.
Outlook, Risks, and Management Commentary
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. The filing notes that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the shares held by the GSK Trust in the same capacity as other employees. No specific guidance, risks, or unusual items regarding business operations are disclosed in this text.
Investor Verification Points
- Verify the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period.
- Confirm the specific dates of transfer versus the dates the Company was advised of these transactions.
- Review the status of the GSK Trust as a discretionary trust for employee beneficiaries.
- Note that this filing does not contain financial results; refer to Form 20-F for comprehensive financial data.